Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes. Alghamdi M, Dihoum A, Hakami K, Bhattacharjee A, et al. Diabetes Obes Metab 2025 Oct 6. doi: 10.1111/dom.70164.

Read + Share

Amedeo Smart

Independent Medical Education

Alghamdi M, Dihoum A, Hakami K, Bhattacharjee A, et al. Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes. Diabetes Obes Metab 2025 Oct 6. doi: 10.1111/dom.70164.
PMID: 41053997